Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
9.74
-0.61 (-5.89%)
At close: Sep 25, 2026, 4:00 PM EDT
9.70
-0.04 (-0.41%)
After-hours: Sep 25, 2026, 7:59 PM EDT
Absci Market Cap
Absci has a market cap or net worth of $1.67 billion as of September 25, 2026. Its market cap has increased by 348.96% in one year.
Market Cap
1.67B
Enterprise Value
1.47B
1-Year Change
348.96%
Ranking
Category
Stock Price
$9.74
ChartMarket Cap Chart
Since the IPO on July 22, 2021, Absci's market cap has increased from $423.19M to $1.67B, an increase of 294.98%. That is a compound annual growth rate of 30.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 1.67B | 218.51% |
| Dec 31, 2025 | 524.80M | 74.40% |
| Dec 31, 2024 | 300.92M | -22.91% |
| Dec 29, 2023 | 390.34M | 101.18% |
| Dec 30, 2022 | 194.03M | -74.44% |
| Dec 31, 2021 | 759.25M | 79.41% |
| Jul 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.75B |
| Novavax | 1.74B |
| Intellia Therapeutics | 1.73B |
| Hemab Therapeutics Holdings | 1.72B |
| Kailera Therapeutics | 1.70B |
| Stoke Therapeutics | 1.68B |
| Rapport Therapeutics | 1.64B |
| Immunocore Holdings | 1.62B |